跳至主要内容
临床试验/NCT00853853
NCT00853853Unknown不适用

Randomized Trial Comparing Standard Ferguson Technique With the EnSeal Device During Hemorrhoidectomy

Steven Schechter, M.D.2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
to examine the advantage and disadvantages of the EnSeal device as it applies to hemorrhoidal surgery and document outcomes as compared to the traditional closed Ferguson hemorrhoidectomy

研究概览

简要总结

This study will compare hemorrhoid surgery by comparing a sutureless heating device with the old standard hemorrhoid surgery. Patients will be followed closely for wound healing and satisfaction.

Hypothesis: The sutureless device will be less painful for the patient and easier for the surgeon to perform.

详细描述

The EnSeal Device is approved for laparoscopic surgery in ligating and dividing vascular tissue during abdominal surgery. Electrical energy is converted into heat energy and resultant simultaneous division of tissues. This allows surgery to be bloodless and sutureless. This device is being used in the current study in the treatment of hemorrhoidal disease where vascular tissue is excised in bloodless and sutureless fashion. The device is FDA-approved for laparoscopic surgery. This is currently being used in institutions throughout the United States and Europe.

This study is looking at the EnSeal device and comparing it to a gold standard hemorrhoidal procedure to see if the OR procedure can be simplified and the postoperative course improved.

The trial is a randomized, controlled, prospective study. Patients will be informed of the two techniques being studied and will be randomized in the operating room by opening up an envelope with the procedure to be employed inside. The envelopes will be numbered 1 through 100, with 50 envelopes containing a slip of paper stating that the surgery will be done using the Ferguson technique and 50 envelopes containing a slip of paper stating the that the surgery will be done using the EnSeal device. These slips of paper will be placed in the envelopes and sealed. The envelopes will be mixed up by someone not involved in the study and then numbered 1 through 100. No one will know which surgical technique will be used on the patient until the surgeon opens the envelope on the day of surgery.

Patients will be followed postoperatively in the office during week 1, week 4, and week 12. At this time, they will be assessed for postoperative complications including but not limited to: bleeding, urinary retention, infection, fecal impaction, hospital re-admission and pain. Delayed complications will also be followed including urinary retention, impaired healing, constipation, abscess, fistula formation, fissure, stenosis, fecal incontinence, and flatus incontinence. The patient's pain score will be assessed using the Universal Pain Assessment Tool, allowing the patient to describe their pain level on a scale between 1 and 10.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men & woman between ages 18-
  • ASA level I, II, and III.
  • External hemorrhoids may or may not be present.
  • Internal hemorrhoids at least Grade II, III, and IV.

排除标准

  • Age less than 18, or greater than
  • ASA level IV.
  • Grade I internal hemorrhoids.
  • Patients on Coumadin, Plavix, or other anticoagulant.
  • Associated procedure such as sphincterotomy, drainage of abscess, fistulotomy, or the like.
  • Pregnancy - Women who have a positive urine pregnancy test pre-op will be excluded from the study.
  • Inflammatory bowel disease.
  • History of chronic active hepatitis B, C, or HIV infection.
  • Lactating women.
  • Inability to follow up with surgeon in office at 1 week, 4 weeks, and 3 months postoperatively.
  • Prior chronic narcotic use (> 30 days)

结局指标

主要结局

to examine the advantage and disadvantages of the EnSeal device as it applies to hemorrhoidal surgery and document outcomes as compared to the traditional closed Ferguson hemorrhoidectomy

时间窗: 1 week, 4 weeks and 12 weeks

次要结局

未报告次要终点

研究者

发起方
Steven Schechter, M.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Steven Schechter, M.D.

Site Director of Colorectal Fellowship program for The Miriam Hospital affiliated with Brown University Program in Colorectal Surgery

The Miriam Hospital

研究点 (2)

Loading locations...

相似试验

EnSeal Device Versus Ferguson Technique in... | 临床试验